Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 2,000 shares at $450.00 ($900K) on 2017-09-29, disclosed to the SEC on 2017-10-03.
Open-market sale of $900k REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |
| REGN | SELL | 2013-10-02 | $4.7M | — | Filing → |